These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15740935)

  • 1. Synergistic anti-viral effect of oxanosine and ddI against human immunodeficiency virus.
    Nakamura M; Ogawa T; Yokono A; Nakamori S; Ohno T; Umezawa K
    Biomed Pharmacother; 2005; 59(1-2):47-50. PubMed ID: 15740935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
    Gong YF; Srinivas RV; Fridland A
    Mol Pharmacol; 1993 Jul; 44(1):30-6. PubMed ID: 8341276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
    Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
    J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
    Balzarini J; Lee CK; Schols D; De Clercq E
    Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New combinations beat HIV in vitro.
    Nurs Stand; 1993 Mar 17-23; 7(26):17. PubMed ID: 8481305
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine riboside.
    Balzarini J; Naesens L; Robins MJ; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1990; 3(12):1140-7. PubMed ID: 2123003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.
    Flandre P; Chappey C; Marcelin AG; Ryan K; Maa JF; Bates M; Seekins D; Bernard MC; Calvez V; Molina JM
    J Infect Dis; 2007 Feb; 195(3):392-8. PubMed ID: 17205478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
    Toma S; Yamashiro T; Arakaki S; Shiroma J; Maeshiro T; Hibiya K; Sakamoto N; Kinjo F; Tateyama M; Fujita J
    J Viral Hepat; 2009 Jul; 16(7):506-12. PubMed ID: 19302339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
    Stevens M; Balzarini J; Tabarrini O; Andrei G; Snoeck R; Cecchetti V; Fravolini A; De Clercq E; Pannecouque C
    J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Didanosine causes sensory neuropathy in an HIV/AIDS animal model: impaired mitochondrial and neurotrophic factor gene expression.
    Zhu Y; Antony JM; Martinez JA; Glerum DM; Brussee V; Hoke A; Zochodne D; Power C
    Brain; 2007 Aug; 130(Pt 8):2011-23. PubMed ID: 17616550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells.
    Dornsife RE; St Clair MH; Huang AT; Panella TJ; Koszalka GW; Burns CL; Averett DR
    Antimicrob Agents Chemother; 1991 Feb; 35(2):322-8. PubMed ID: 1708977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of combinations of ampligen and zidovudine or dideoxyinosine against human immunodeficiency viruses in vitro.
    O'Marro SD; Armstrong JA; Asuncion C; Gueverra L; Ho M
    Antiviral Res; 1992 Feb; 17(2):169-77. PubMed ID: 1554239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS).
    Mayhew C; Oakley O; Piper J; Hughes NK; Phillips J; Birch NJ; Elford HL; Gallicchio VS
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1019-29. PubMed ID: 9449534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model.
    Harvie P; Omar RF; Dusserre N; Lansac N; Désormeaux A; Gourde P; Simard M; Tremblay M; Beauchamp D; Bergeron MG
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1009-17. PubMed ID: 8930211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells.
    Carter MM; Torres SM; Cook DL; McCash CL; Yu M; Walker VE; Walker DM
    Environ Mol Mutagen; 2007; 48(3-4):239-47. PubMed ID: 17358029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the combination effect of different antiviral compounds against HIV in vitro.
    Sørensen AM; Nielsen C; Mathiesen LR; Nielsen JO; Hansen JE
    Scand J Infect Dis; 1993; 25(3):365-71. PubMed ID: 7689746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.
    Assoumou L; Brun-Vézinet F; Cozzi-Lepri A; Kuritzkes D; Phillips A; Zolopa A; Degruttola V; Miller V; Costagliola D;
    J Infect Dis; 2008 Aug; 198(4):470-80. PubMed ID: 18598191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiating effect of (2-[2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methyl]-phenyl]ethenyl) -phosphonic acid (MDL 74,428), a potent inhibitor of purine nucleoside phosphorylase, on the antiretroviral activities of 2',3'-dideoxyinosine combined with ribavirin in mice.
    Weibel M; Balzarini J; Bernhardt A; Mamont P
    Biochem Pharmacol; 1994 Jul; 48(2):245-52. PubMed ID: 8053921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifunctional properties of analogues of modified nucleotides: immune system cells stimulation and human immunodeficiency virus (HIV) replication inhibition.
    Pisarev VM; Tarussova NB; Leskov VP; Kremlev SG; Kuhanova MK; Tutelyan AV; Otrazheva ED; Pevnitzky LA
    Nucleic Acids Symp Ser; 1991; (24):21. PubMed ID: 1841287
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
    Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
    J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.